IVHD-valtrate CAS 28325-56-6

Introduction：Basic information about IVHD-valtrate CAS 28325-56-6, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

IVHD-valtrate Basic information

• Product Name: IVHD-valtrate
• Synonyms: IVHD-valtrate;Isovaleroxyhydroxydidrovaltratum;Isovaleroxyhydroxydihydrovaltrate;Valtrate HD;Butanoic acid, 3-methyl-2-(3-methyl-1-oxobutoxy)-, [(1S,2'R,4aR,6S,7aS)-6-(acetyloxy)-4a,5,6,7a-tetrahydro-4a-hydroxy-1-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-4-yl]methyl ester
• CAS: 28325-56-6
• MF: C27H40O11
• MW: 540.6
• Mol File: 28325-56-6.mol

IVHD-valtrate Usage And Synthesis

Uses

IVHD-valtrate, an active Valeriana jatamansi derivative, is against human ovarian cancer cells in vitro and in vivo. IVHD-valtrate induces cancer cells apoptosis and arrests the ovarian cancer cells in the G2/M phase. IVHD-valtrate has the potential to be a novel chemotherapeutic agent for the human ovarian cancer research[1].

Biological Activity

IVHD-valtrate is an active Valeriana jatamansi derivative that inhibits human ovarian cancer cells in vitro and in vivo. It induces apoptosis of cancer cells and inhibits ovarian cancer cells from arresting in G2/M phase. It has the potential to be a new chemotherapeutic agent for human ovarian cancer research.

in vitro

IVHD-valtrate inhibits the growth and proliferation of the A2780 and OVCAR-3 ovarian cancer cell lines in a concentration-dependent manner. IVHD-valtrate results in a relatively low cytotoxicity to immortalized non-tumorigenic human ovarian surface epithelial cells (IOSE-144).

target

IC50: apoptosis

References

[1] Xiaoguang Li, et al. Valeriana jatamansi constituent IVHD-valtrate as a novel therapeutic agent to human ovarian cancer: in vitro and in vivo activities and mechanisms. Curr Cancer Drug Targets. 2013 May;13(4):472-83. DOI:10.2174/1568009611313040009